Vir Biotechnology Inc
NASDAQ:VIR

Watchlist Manager
Vir Biotechnology Inc Logo
Vir Biotechnology Inc
NASDAQ:VIR
Watchlist
Price: 4.73 USD 1.94% Market Closed
Market Cap: 653m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

VIR Price Targets Summary
Vir Biotechnology Inc

Wall Street analysts forecast VIR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VIR is 34.24 USD with a low forecast of 14.14 USD and a high forecast of 115.5 USD.

VIR Lowest Forecast
Wall Street Target
14.14 USD
199% Upside
VIR Average Forecast
Wall Street Target
34.24 USD
624% Upside
VIR Highest Forecast
Wall Street Target
115.5 USD
2 342% Upside
Lowest
Price Target
14.14 USD
199% Upside
Average
Price Target
34.24 USD
624% Upside
Highest
Price Target
115.5 USD
2 342% Upside
Vir Biotechnology Inc Competitors:
Price Targets
FHTX
Foghorn Therapeutics Inc.
160% Upside
AMGN
Amgen Inc
16% Upside
IDYA
IDEAYA Biosciences Inc
168% Upside
1801
Innovent Biologics Inc
8% Upside
FHTX
Foghorn Therapeutics Inc.
160% Upside
AMGN
Amgen Inc
16% Upside
IDYA
IDEAYA Biosciences Inc
168% Upside
1801
Innovent Biologics Inc
8% Upside
KMDA
Kamada Ltd
119% Upside
NTRA
Natera Inc
29% Upside

Revenue
Forecast

Revenue Estimate
Vir Biotechnology Inc

For the last 6 years the compound annual growth rate for Vir Biotechnology Inc's revenue is 38%. The projected CAGR for the next 3 years is -15%.

38%
Past Growth
-15%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Vir Biotechnology Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Vir Biotechnology Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

See Also

Summary
VIR intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIR stock valuation using valuation multiples.
Wall Street Estimates
VIR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VIR's stock price target?
Price Target
34.24 USD

According to Wall Street analysts, the average 1-year price target for VIR is 34.24 USD with a low forecast of 14.14 USD and a high forecast of 115.5 USD.

What is Vir Biotechnology Inc's Revenue forecast?
Projected CAGR
-15%

For the last 6 years the compound annual growth rate for Vir Biotechnology Inc's revenue is 38%. The projected CAGR for the next 3 years is -15%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.